期刊论文详细信息
BMC Gastroenterology
Effect of 5-HT7 receptor blockade on liver regeneration after 60-70% partial hepatectomy
Georgios I Panoutsopoulos2  Dimitrios Panidis3  Ioannis Protopsaltis4  Agni D Grypioti5  Maria Tsironi3  Vassiliki Papalimneou1  Sofia Zyga3  Kalliopi T Kourentzi5  Konstantinos N Tzirogiannis5 
[1] Department of Internal Medicine, Elpis General Hospital, Athens 11522, Greece;Department of Nursing, Faculty of Human Movement and Quality of Life Sciences, University of Peloponnese, Orthias Artemidos and Plateon, Sparta 23100, Greece;Department of Nursing, Faculty of Human Movement and Quality of Life Sciences, University of Peloponnese, Sparta 23100, Greece;Department of Internal Medicine, Tzanio General Hospital of Piraeus, Piraeus 18537, Greece;Department of Experimental Pharmacology, Medical School, Athens University, Athens 11527, Greece
关键词: AS-19;    SB-258719;    SB-269970;    5-HT7 receptor;    Partial hepatectomy;    Liver regeneration;   
Others  :  1121750
DOI  :  10.1186/s12876-014-0201-2
 received in 2014-02-28, accepted in 2014-11-11,  发布年份 2014
PDF
【 摘 要 】

Background

Serotonin exhibits a vast repertoire of actions including cell proliferation and differentiation. The effect of serotonin, as an incomplete mitogen, on liver regeneration has recently been unveiled and is mediated through 5-HT2 receptor. The aim of the present study was to investigate the effect of 5-HT7 receptor blockade on liver regeneration after partial hepatectomy.

Methods

Male Wistar rats were subjected to 60-70% partial hepatectomy. 5-HT7 receptor blockade was applied by intraperitoneal administration of SB-269970 hydrochloride two hours prior to and sixteen hours after partial hepatectomy and by intraperitoneal administration of SB-258719 sixteen hours after partial hepatectomy. Animals were sacrificed at different time points until 72 h after partial hepatectomy. Liver regeneration was evaluated by [3H]-thymidine incorporation into hepatic DNA, the mitotic index in hematoxylin-eosin (HE) sections and by immunochemical detection of Ki67 nuclear antigen. Reversion of 5-HT7 blockade was performed by intraperitoneal administration of AS-19. Serum and liver tissue lipids were also quantified.

Results

Liver regeneration peaked at 24 h ([3H]-thymidine incorporation into hepatic DNA and mitotic index by immunochemical detection of Ki67) and at 32 h (mitotic index in HE sections) in the control group of rats. 5-HT7 receptor blockade had no effect on liver regeneration when applied 2 h prior to partial hepatectomy. Liver regeneration was greatly attenuated when blockade of 5-HT7 receptor was applied (by SB-258719 and SB-269970) at 16 h after partial hepatectomy and peaked at 32 h ([3H]-thymidine incorporation into hepatic DNA and mitotic index by immunochemical detection of Ki67) and 40 h (mitotic index in HE sections) after partial hepatectomy. AS-19 administration totally reversed the observed attenuation of liver regeneration.

Conclusions

In conclusion, 5-HT7 receptor is a novel type of serotonin receptor implicated in hepatocyte proliferation.

【 授权许可】

   
2014 Tzirogiannis et al.; licensee BioMed Central Ltd.

【 预 览 】
附件列表
Files Size Format View
20150213011256709.pdf 1299KB PDF download
Figure 11. 12KB Image download
Figure 10. 45KB Image download
Figure 9. 45KB Image download
Figure 8. 13KB Image download
Figure 7. 16KB Image download
Figure 6. 13KB Image download
Figure 5. 13KB Image download
Figure 4. 9KB Image download
Figure 4. 22KB Image download
Figure 2. 13KB Image download
Figure 1. 14KB Image download
【 图 表 】

Figure 1.

Figure 2.

Figure 4.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

Figure 8.

Figure 9.

Figure 10.

Figure 11.

【 参考文献 】
  • [1]Ruddell RG, Mann DA, Ramm GA: The function of serotonin within the liver. J Hepatol 2008, 48:666-675.
  • [2]Beattie DT, Smith JA: Serotonin Pharmacology in the gastrointestinal tract: a review. Naunyn Schmiedebergs Arch Pharmacol 2008, 377:181-203.
  • [3]Lesurtel M, Soll C, Graf R, Clavien PA: Role of serotonin in the hepato-gastrointestnal tact: an old molecule for new perspectives. Cell Mol Life Sci 2008, 65:940-952.
  • [4]Ruddel RG, Oakley F, Hussain Z, Yeung I, Bryan-Lluka LJ, Ramm GA, Mann DA: A Role for Serotonin (5-HT) in hepatic Stellate Cell Function and Liver Fibrosis. Am J Pathol 2006, 169:861-876.
  • [5]Kulinskii VI, Saratikov AS, Vstavskaia IA, Udovitsina TI: Receptors mediating serotonin-stimulating liver regeneration in mice. Biull Eksp Biol Med 1983, 95:89-91.
  • [6]Kulinskii VI, Udovitsina TI, Vstavskaia IA, Rykov SA: Comparison of the changes in mitotic activity and in serotonin concentration in regenerating liver. Vopr Med Khim 1983, 29:104-107.
  • [7]Balasubramanian S, Paulose CS: Induction of DNA synthesis in primary cultures of rat hepatocytes by serotonin: possible involvement of serotonin S2 receptor. Hepatology 1998, 27:62-66.
  • [8]Papadimas GK, Tzirogiannis KN, Panoutsopoulos GI, Demonakou MD, Skaltsas SD, Hereti RI, Papadopoulou-Daifoti Z, Mykoniatis MG: Effect of serotonin receptor 2 blockade on liver regeneration after partial hepatectomy in the rat liver. Liver Int 2006, 26:352-361.
  • [9]Lesurtel M, Graf R, Aleil B, Walther DJ, Tian Y, Jochum W, Gachet C, Bader M, Clavien PA: Platelet-derived serotonin mediates liver regeneration. Science 2006, 312:104-107.
  • [10]Soll C, Jang JH, Riener MO, Moritz W, Wild PJ, Graf R, Clavien PA: Serotonin promotes tumor growth in Human Hepatocellular Cancer. Hepatology 2010, 51:1244-1254.
  • [11]Vanhoenacker P, Haegeman G, Leysen JE: 5-HT7 receptors: current knowledge and future prospects. Trends Pharmacol Sci 2000, 21:70-77.
  • [12]Hedlund PB, Sutcliffe JG: Functional, molecular and pharmacological advances in 5-HT 7 receptor research. Trends Pharmacol Sci 2004, 25:481-486.
  • [13]Protection of Animals Used for Experimental and Other Scientific Purposes in Accordance With EU Directive 86/609/EEC of the Council. 1991.
  • [14]Munro HN, Fleck A: Recent developments in the measurement of nucleic acids in biological materials. Analyst 1966, 91:78-88.
  • [15]Kyprianidis KG, Mykoniatis MG, Papadimitriou DG, Valsamidou A: Effect of subtotal pancreatectomy on the rate of liver regeneration: the role of hepatic stimulator substance. J Surg Res 1996, 62:267-272.
  • [16]Richards G: Modifications of the diphenylamine reaction giving increased sensitivity and simplicity in the estimation of DNA. Anal Biochem 1974, 57:369-376.
  • [17]Lowry O, Rosenbrough N, Farr A, Randall R: Protein measurement with the folin phenol reagent. J Biol Chem 1951, 193:265-275.
  • [18]Folch J, Lees M, Sloane Stanley GH: A simple method for the isolation and purification of total lipids from animal tissues. J Biol Chem 1982, 28:497-509.
  • [19]Tijburg LB, Maquedano A, Bijleveld C, Guzman M, Geelen MJ: Effects of ethanol feeding on hepatic lipid synthesis. Arch Biochem Biophys 1988, 267:568-579.
  • [20]Michalopoulos GK: Liver regeneration after partial Hepatectomy: critical analysis of mechanistic dilemmas. Am J Pathol 2010, 176:2-13.
  • [21]Tanaka K, Ohkawa S, Nishino T, Niijima A, Inoue S: Role of the hepatic branch of the vagus nerve in lever regeneration in rats. Am J Physiol 1987, 253:G439-G444.
  • [22]Oben JA, Diehl AM: Sympathetic nervous system regulation of liver repair. Anat Rec A: Discov Mol Cell Evol Biol 2004, 280:874-883.
  • [23]Cruise JL, Knechtle SJ, Bollinger RR, Kuhn C, Michalopoulos G: Alpha 1-adrenergic effects and liver regeneration. Hepatology 1987, 7:1189-1194.
  • [24]Cruise JL, Houck KA, Michalopoulos G: Early events in the regulation of Hepatocyte DNA synthesis: the role of alpha- adrenergic stimulation. Scand J Gastroenterol 1988, 151:19-30.
  • [25]Cruise JL, Houck KA, Michalopoulos GK: Induction of DNA synthesis in cultured rat hepatocytes through stimulation of alpha 1 adrenoreceptor by norepinephrine. Science 1985, 227:749-751.
  • [26]Refsnes M, Thoresen GH, Sandnes D, Dajani OF, Dajani L, Christoffersen T: Stimulatory and inhibitory effects of catecholamines on DNA synthesis in primary rat hepatocyte cultures: role of alpha1- and beta-adrenergic mechanisms. J Cell Physiol 1992, 151:164-171.
  • [27]El-Salhy M, Stenling R, Grimelius L: Peptidergic innervation and endocrine cells in the human liver. Scand J Gastroenterol 1993, 28:809-815.
  • [28]Stoyanova JL: Relevance of mast cells and hepatic lobule innervations to liver. Rom J Gastroenterol 2004, 13:203-209.
  • [29]Brauneis U, Gatmaitan Z, Arias IM: Serotonin stimulates a Ca2+permeant nonspecific cation channel in hepatic endothelial cells.Biochem Biophys Res Commun 1992, 186:1560–1566.
  • [30]Gatmaitan Z, Varticovski L, Ling L, Mikkelsen R, Steffan AM, Arias IM: Studies on fenestral contraction in rat liver endothelial cells in culture. Am J Pathol 1996, 148:2027-2041.
  • [31]Clavien PA: Liver regeneration: a spotlight on the novel role of platelets and serotonin. Swiss Med Wkly 2008, 138:361-370.
  • [32]Gooz M, Gooz P, Luttrell LM, Raymond JR: 5-HT2A receptor induces ERK phosphorylation and proliferation through ADAM-17 tumor necrosis factor-alpha-converting enzyme (TACE) activation and heparin-bound epidermal growth factor-like growth factor (HB-EGF) shedding in mesangial cells. J Biol Chem 2006, 281:21004-21012.
  • [33]Nebigil CG, Launay JM, Hickel P, Tournois C, Maroteaux L: 5-hydroxytrypramine 2B receptor regulates cell-cycle progression: cross-talk with tyrosine kinase pathways. Proc Natl Acad Sci U S A 2000, 97:2591-2596.
  • [34]Liu Y, Li M, Warburton RR, Hill NS, Fanburg BL: The 5-HT transporter transactivates the PDGF beta receptor in pulmonary artery smooth muscle cells. FASEB J 2007, 21:2725-2734.
  • [35]Mnie-Filali O, Faure C, Lambas-Senas L, El Mansari M, Belblidia H, Gondard E, Etievant A, Scarna H, Didier A, Berod A, Blier P, Haddjeri N: Pharmacological blockade of 5-HT7 receptors as a putative fast acting antidepressant strategy. Neuropsychopharmacology 2011, 36:1275-1288.
  • [36]Leon-Ponte M, Ahern GP, O’Connell PJ: Serotonin provides an accessory signal to enhance T-cell activation by signaling through the 5-HT7 receptor. Blood 2007, 109:3139-3146.
  • [37]Svejda B, Kidd M, Timberlake A, Harry K, Kazberouk A, Schimmack S, Lawrence B, Pfragner R, Modlin IM: Serotonin and the 5-HT7 receptor: the link between hepatocytes, IGF-1 and small intestinal neuroendocrine tumors. Cancer Sci 2013, 104:844-855.
  • [38]Mahe C, Loetscher E, Feuerbach D, Muller W, Seiler MP, Schoeffter P: Differential inverse agonist efficacies of SB-258719, SB-258741 and SB-269970 at human recombinant serotonin 5-HT7 receptors. Eur J Pharmacol 2004, 495:97-102.
  • [39]Lovell PJ, Bromidge SM, Dabbs S, Duckworth DM, Forbes IT, Jennings AJ, King FD, Middlemiss DN, Rahman SK, Saunders DV, Collin LL, Hagan JJ, Riley GJ, Thomas DR: A novel, potent, and selective 5-HT7 antagonist: (R)-3-(2-(2-(4-methylpiperidin-1-yl)ethyl)pyrrolidine-1-sulfonyl)phenol (SB 269970). J Med Chem 2000, 43:342-345.
  • [40]Foong JP, Bornstein JC: 5-HT antagonists NAN-190 and SB 269970 block αlpha2-adrenoceptors in the guinea pig. Neuroreport 2009, 20:325-330.
  • [41]Hagan JJ, Price GW, Jeffrey P, Deeks NJ, Stean T, Piper D, Smith MI, Upton N, Medhurst AD, Middlemiss DN, Riley GJ, Lovell PJ, Bromidge SM, Thomas DR: Characterization of SB-269970-A, a selective 5-HT(7) receptor antagonist. Br J Pharmacol 2000, 130:539-548.
  • [42]Hoffman BB, Dukes DF, Lefkowitz RJ: Alpha-adrenergic receptors in liver membranes: delineation with subtype selective radioligands. Life Sci 1981, 28:265-272.
  • [43]Bylund DB: Subtypes of αlpha-1- and alpha-2- adrenergic receptors. FASEB J 1992, 6:832-839.
  • [44]Seuwen K, Magnaldo I, Kobilka BK, Caron MG, Regan JW, Lefkowitz RJ, Pouyssegur J: Alpha 2-adrenergic agonists stimulate DNA synthesis in Chinese hamster lung fibroblasts transfected with a human alpha 2-adrenergic receptor gene. Cell Regul 1990, 1:445-451.
  • [45]Chiesa IJ, Castillo LF, Luthy IA: Contribution of alpha-2-adrenoceptors to the mitogenic effect of catecholestrogen in human breast cancer MCF-7 cells. J Steroid Biochem Mol Biol 2008, 110:170-175.
  • [46]Bruzzone A, Pinero CP, Castillo LF, Sarappa MG, Rojas P, Lanari C, Luthy IA: Alpha-2- adrenoceptor action on cell proliferation and mammary tumour growth in mice. Br J Pharmacol 2008, 155:494-504.
  • [47]Shen SG, Zhang D, Hu HT, Li JH, Wang Z, Ma QY: Effects of alpha-adrenoreceptor antagonists on apoptosis and proliferation of pancreatic cancer cells in vitro. World J Gastroenterol 2008, 14:2358-2363.
  • [48]Kanno N, Lesage G, Phinizy JL, Glaser S, Francis H, Alpini G: Stimulation of alpha2-adrenergic receptor inhibits cholangiocarcinoma growth through modulation of Raf-1 and B-Raf activities. Hepatology 2002, 35:1329-1340.
  • [49]Romero G, Pujol M, Pauwels PJ: Reanalysis of constitutively active rat and human 5-HT7(a) receptors in HEK-293 F cells demonstates lack of silent properties for reported neutral antagonists. Naunyn Schmiedebergs Arch Pharmacol 2006, 374:31-39.
  • [50]Forbes IT, Dabbs S, Duckworth DM, Jennings AJ, King FD, Lovell PJ, Brown AM, Collin L, Hagan JJ, Middlemiss DN, Riley GJ, Thomas DR, Upton N: (R)-3, N-dimethyl-N-[1-methyl-3-(4-methyl-piperidin-1-yl) propyl]benzenesulfonamide: the first selective 5–HT7 receptor antagonist. J Med Chem 1998, 41:655-657.
  • [51]Perez-Garcia GS, Meneses A: Effects of the potential 5-HT7 receptor agonist AS 19 in an autoshaping learning task. Behav Brain Res 2005, 163:136-140.
  • [52]Perez-Garcia G, Gonzalez-Espinosa C, Meneses A: An mRNA expression analysis of stimulation and blockade of 5-HT7 receptors during memory consolidation. Behav Brain Res 2006, 169:83-92.
  • [53]Sanin A, Brisander M, Rosqvist S, Mohell N, Malberg A, Johansson A: 5-Aryl Substituted (S)-2-(Dimethylamino)-Tetralins Nover Serotonin 5HT 7 Receptor Ligands. Proceedings of the 14th Camerino-Noord Symposium 2004, 27.
  • [54]Brenchat A, Rocasalbas M, Zamanillo D, Hamon M, Miguel Vela J, Romero L: Assessment of 5-HT7 receptor agonists selectivity using nociceptive and thermoregulation tests in knockout versus wild-type mice. Adv Pharmacol Sci 2012, 2012:312041.
  • [55]Tijburg LB, Nyathi CB, Meijer GW, Geelen MJ: Biosynthesis and secretion of triacylglycerol in rat liver after partial hepatectomy. Biochem J 1991, 277:723-728.
  • [56]Rudnick DA: Trimming the fat from liver regeneration. Hepatology 2005, 42:1001-1003.
  • [57]Sumara G, Sumara O, Kim JK, Karsenty G: Gut-derived serotonin is a multifunctional determinant to fasting adaptation. Cell Metab 2012, 16:588-600.
  • [58]Nonogaki K: New insights into sympathetic regulation of glucose and fat metabolism. Diabetologia 2000, 43:533-549.
  • [59]Watts SW, Yang P, Banes AK, Baez M: Activation of Erk mitogen-activated protein kinase proteins by vascular serotonin receptors. J Cardiovasc Pharmacol 2001, 38:539-551.
  • [60]Lieb K, Biersack L, Waschbiisch A, Orlikowski S, Akundi ES, Candelario-Jalil E, Hull M, Fiebich BL: Serotonin via 5-HT7 receptors activates p38 mitogen-activated protein kinase and protein kinase C epsilon resulting in interleukin-6 synthesis in human U373 MG astrocytoma cells. J Neurochem 2005, 93:549-559.
  • [61]Norum JH, Hart K, Levy FO: Ras-dependent ERK activation by the human G(s)-coupled serotonin receptors 5-HT4(b) and 5-HT7(a). J Biol Chem 2003, 278:3098-3104.
  • [62]Klinger M, Kudlacek O, Seidel MG, Freissmuth M, Sexl V: MAP kinase stimulation by cAMP does not require RAP1 but SRC family kinases. J Biol Chem 2002, 277:32490-32497.
  • [63]Enserink JM, Christensen AE, de Rooij J, van Triest M, Schwede F, Genieser HG, Doskeland SO, Blank JL, Bos JL: A novel Epac-specific cAMP analogue demonstrates independent regulation of Rap1 and ERK. Nat Cell Biol 2002, 4:901-906.
  • [64]Banes A, Florian JA, Watts SW: Mechanisms of 5-Hydroxytryptamine (2A) receptor activation of the mitogen-activated protein kinase pathway in vascular smooth muscle. J Pharmacol Exp Ther 1999, 291:1179-1187.
  文献评价指标  
  下载次数:106次 浏览次数:32次